Bristol-Myers Squibb (BMY) total assets

Total assets · fiscal 2025
$90.04B

Bristol-Myers Squibb (BMY) had total assets of $90.04B at the end of fiscal 2025 (December 31, 2025). That is 2.8% lower than the $92.60B of fiscal 2024. Figures as of 18 Nov 2026, 05:03 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$90.04B
Change on fiscal 2024
−2.8%
Growth, 5 years
−5.3% a year
Growth, 10 years
+11.0% a year
Highest on record
$129.94Bfiscal 2019
Lowest on record
$29.49Bfiscal 2008
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Bristol-Myers Squibb total assets, in more detail

Over the five fiscal years to 2025 total assets shrank at a compound 5.3% a year; over ten years the rate was 11.0% a year. Across the 18 fiscal years on record (2008–2025), the highest was $129.94B in fiscal 2019 and the lowest $29.49B in fiscal 2008.

History · 18 fiscal years

Total assets by fiscal year

Bristol-Myers Squibb total assets, year by year

Bristol-Myers Squibb (BMY) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$90.04B 2.8% down
2024$92.60B 2.7% down
2023$95.16B 1.7% down
2022$96.82B 11.4% down
2021$109.31B 7.7% down
2020$118.48B 8.8% down
2019$129.94B 271.4% up
2018$34.99B 4.3% up
2017$33.55B 0.5% down
2016$33.71B 6.2% up
2015$31.75B 5.9% down
2014$33.75B 12.5% down
2013$38.59B 7.5% up
2012$35.90B 8.9% up
2011$32.97B 6.1% up
2010$31.08B 0.2% up
2009$31.01B 5.2% up
2008$29.49B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

Total assets at health care companies of similar size

Total assets of Bristol-Myers Squibb and comparable companies
CompanyTotal assetsFiscal year
Vertex Pharmaceuticals VRTX$25.64B2025
Medtronic MDT$93.03B2026
Bristol-Myers Squibb BMY$90.04B2025
Stryker SYK$47.84B2025
McKesson MCK$82.32B2026
Sanofi SNY€126.81B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BMY

Bristol-Myers Squibb, figure by figure

Bristol-Myers Squibb (BMY) overview: price, valuation and scorecardAll health care companies by market value

Bristol-Myers Squibb total assets: questions and answers

How large are Bristol-Myers Squibb's total assets?

Bristol-Myers Squibb (BMY) had total assets of $90.04B at the end of fiscal 2025 (December 31, 2025). That is 2.8% lower than the $92.60B of fiscal 2024.

What is the growth rate of Bristol-Myers Squibb's total assets?

Over the five fiscal years to 2025 total assets shrank at a compound 5.3% a year; over ten years the rate was 11.0% a year.

What are the highest and lowest total assets figures on record for Bristol-Myers Squibb?

Across the 18 fiscal years on record (2008–2025), the highest was $129.94B in fiscal 2019 and the lowest $29.49B in fiscal 2008.

How is Bristol-Myers Squibb's total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bristol-Myers Squibb (BMY) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/BMY/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.